StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Northwest Biotherapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Northwest Biotherapeutics's pe ratio was 0.0× on Jan 31, 2023, against 76.8× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 20230.0×−0.0
2022Dec 30, 20220.0×−76.8
2020Jul 31, 202076.8×–

More Northwest Biotherapeutics figures

See a number that looks wrong?